MediWound Company Profile (NASDAQ:MDWD)

About MediWound

MediWound logoMediWound Ltd. is a biopharmaceutical company focused on developing, manufacturing and commercializing products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's biopharmaceutical product, NexoBrid, received marketing authorization from the European Union agency (EMA) and the Israeli and Argentinean ministries of health for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns, also referred to as severe burns. NexoBrid is based on the Company's proteolytic enzyme technology. NexoBrid is a topically-applied product that removes eschar in approximately four hours without harming the surrounding healthy tissues. The Company offers NexoBrid in Europe and Israel. NexoBrid has been investigated in over 550 patients across approximately 15 countries and over four continents in approximately six completed Phase II and Phase III clinical studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MDWD
  • CUSIP:
Key Metrics:
  • Previous Close: $5.85
  • 50 Day Moving Average: $5.65
  • 200 Day Moving Average: $6.25
  • 52-Week Range: $4.25 - $8.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.29
  • P/E Growth: -0.08
  • Market Cap: $128.29M
  • Outstanding Shares: 21,871,000
  • Beta: 0.03
Profitability:
  • Net Margins: -1,776.06%
  • Return on Equity: -148.23%
  • Return on Assets: -53.44%
Debt:
  • Current Ratio: 7.55%
  • Quick Ratio: 7.34%
Additional Links:
Companies Related to MediWound:

Analyst Ratings

Consensus Ratings for MediWound (NASDAQ:MDWD) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.20 (108.55% upside)

Analysts' Ratings History for MediWound (NASDAQ:MDWD)
Show:
DateFirmActionRatingPrice TargetDetails
2/9/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$10.00View Rating Details
11/28/2016AegisInitiated CoverageBuy$11.00View Rating Details
8/17/2016Wells Fargo & CoInitiated CoverageOutperform$14.00View Rating Details
7/29/2016Jefferies Group LLCLower Price TargetBuy$15.00 -> $13.00View Rating Details
4/23/2016Brean CapitalReiterated RatingBuyView Rating Details
3/23/2016SunTrust Banks, Inc.Initiated CoverageBuy$13.00View Rating Details
8/11/2015Credit Suisse GroupLower Price TargetOutperform$18.00 -> $14.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for MediWound (NASDAQ:MDWD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/19/2017        
2/21/201712/31/2016($0.25)($0.09)$0.73 million$0.43 millionViewListenView Earnings Details
11/14/2016Q316($0.26)($0.26)$0.61 million$0.52 millionViewN/AView Earnings Details
7/28/2016Q216($0.23)($0.34)$0.45 million$3.36 millionViewListenView Earnings Details
4/21/2016Q116($0.24)($0.17)$0.28 million$0.25 millionViewListenView Earnings Details
1/25/2016Q415($0.23)($0.36)$0.40 million$0.27 millionViewListenView Earnings Details
10/27/2015Q315($0.31)($0.17)$0.47 million$334.00 millionViewListenView Earnings Details
8/3/2015Q215($0.26)($0.19)$0.22 million$0.17 millionViewListenView Earnings Details
5/4/2015($0.26)($0.30)$0.20 millionViewListenView Earnings Details
2/12/2015Q4($0.26)($0.33)$0.09 millionViewListenView Earnings Details
11/5/2014Q3($0.23)($0.24)$0.10 millionViewListenView Earnings Details
7/31/2014Q2($0.15)($0.28)$0.19 million$0.89 millionViewListenView Earnings Details
5/5/2014($0.11)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MediWound (NASDAQ:MDWD)
Current Year EPS Consensus Estimate: $-0.79 EPS
Next Year EPS Consensus Estimate: $-0.63 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.28)($0.22)($0.25)
Q2 20163($0.25)($0.23)($0.24)
Q3 20163($0.26)($0.17)($0.21)
Q4 20163($0.26)($0.23)($0.25)
Q1 20172($0.19)($0.10)($0.15)
Q2 20172($0.21)($0.18)($0.20)
Q3 20172($0.18)($0.17)($0.18)
Q4 20172($0.18)($0.16)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MediWound (NASDAQ:MDWD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MediWound (NASDAQ:MDWD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for MediWound (NASDAQ:MDWD)
DateHeadline
finance.yahoo.com logoMEDIWOUND LTD. Financials (NASDAQ:MDWD)
finance.yahoo.com - February 24 at 7:42 PM
finance.yahoo.com logoEdited Transcript of MDWD earnings conference call or presentation 21-Feb-17 1:30pm GMT (NASDAQ:MDWD)
finance.yahoo.com - February 22 at 8:18 AM
us.rd.yahoo.com logoMediWound Reports 2016 Fourth Quarter and Full Year Financial Results (NASDAQ:MDWD)
us.rd.yahoo.com - February 21 at 6:25 PM
biz.yahoo.com logoQ4 2016 Mediwound Ltd Earnings Release - 07:00 am ET (NASDAQ:MDWD)
us.rd.yahoo.com - February 21 at 6:25 PM
sg.finance.yahoo.com logoMediWound reports 4Q loss (NASDAQ:MDWD)
sg.finance.yahoo.com - February 21 at 6:25 PM
nasdaq.com logoMediWound to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on February 2 (NASDAQ:MDWD)
www.nasdaq.com - February 14 at 8:00 PM
finance.yahoo.com logoMediWound to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on February 21, 2017 at 8:30 a.m. Eastern Time (NASDAQ:MDWD)
finance.yahoo.com - February 14 at 8:00 PM
nasdaq.com logoFavorable Results from NexoBrid Phase 2 Pharmacokinetic Clinical Study Support Treatment of Severe (NASDAQ:MDWD)
www.nasdaq.com - February 10 at 12:34 AM
us.rd.yahoo.com logoFavorable Results from NexoBrid Phase 2 Pharmacokinetic Clinical Study Support Treatment of Severe Burns Covering up to 30% of Total Body Surface Area (NASDAQ:MDWD)
us.rd.yahoo.com - February 9 at 7:29 PM
streetinsider.com logoMediWound (MDWD) Cleared by EMA to Begin Second Stage of Pediatric Phase 3 Study of NexoBrid (NASDAQ:MDWD)
www.streetinsider.com - February 8 at 12:49 AM
us.rd.yahoo.com logoMediWound Initiates Second Stage of European Pediatric Phase 3 Study of NexoBrid® Expanding Treatment of Severe Burns to Children Age One to Four (NASDAQ:MDWD)
us.rd.yahoo.com - February 6 at 9:58 AM
us.rd.yahoo.com logoMediWound Reports Final Positive Results of Phase 2 Clinical Trial of EscharEx for the Debridement of Chronic and Hard-to-Heal Wounds (NASDAQ:MDWD)
us.rd.yahoo.com - January 31 at 7:22 PM
finance.yahoo.com logo4 Drug Stocks Poised to Surprise this Earnings Season (NASDAQ:MDWD)
finance.yahoo.com - January 28 at 4:58 AM
us.rd.yahoo.com logoWhy Earnings Season Could Be Great for MediWound (MDWD) (NASDAQ:MDWD)
us.rd.yahoo.com - January 21 at 12:16 AM
finance.yahoo.com logoEarnings Estimates Moving Higher for MediWound (MDWD): Time to Buy? (NASDAQ:MDWD)
finance.yahoo.com - January 10 at 7:24 PM
News IconMediWound Ltd MDWD Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:MDWD)
www.bioportfolio.com - January 8 at 1:52 AM
us.rd.yahoo.com logoMediWound Granted U.S. Patent for MWPC003 for the Treatment of Connective Tissue Diseases (NASDAQ:MDWD)
us.rd.yahoo.com - December 20 at 12:15 PM
us.rd.yahoo.com logo7:02 am MediWound announces USPTO issuance of claims related to its MWPC003 for enzymatic treatment of connective tissue diseases (NASDAQ:MDWD)
us.rd.yahoo.com - December 20 at 12:15 PM
News IconMediWound Ltd. (MDWD) Receives Consensus Analysts Rating of ‘Buy’ (NASDAQ:MDWD)
missionir.com - December 9 at 6:32 PM
capitalcube.com logoMediWound Ltd. :MDWD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 (NASDAQ:MDWD)
www.capitalcube.com - November 29 at 2:55 PM
finance.yahoo.com logoAbstract Highlighting NexoBrid® in Burn Mass Casualties Awarded “Best Poster” at the International Disaster and Military Medicine Conference (NASDAQ:MDWD)
finance.yahoo.com - November 18 at 8:53 AM
finance.yahoo.com logoEdited Transcript of MDWD earnings conference call or presentation 14-Nov-16 1:30pm GMT (NASDAQ:MDWD)
finance.yahoo.com - November 15 at 9:48 AM
tmcnet.com logoMediWound Reports Third Quarter 2016 Financial Results (NASDAQ:MDWD)
www.tmcnet.com - November 14 at 10:11 AM
sg.finance.yahoo.com logoMediWound reports 3Q loss (NASDAQ:MDWD)
sg.finance.yahoo.com - November 14 at 10:11 AM
finance.yahoo.com logoMediWound to Host Third Quarter 2016 Financial Results Conference Call on November 14, 2016 at 8:30 a.m. Eastern Time (NASDAQ:MDWD)
finance.yahoo.com - November 4 at 9:19 AM
finance.yahoo.com logoMediWound to Present at the Credit Suisse 25th Annual Healthcare Conference (NASDAQ:MDWD)
finance.yahoo.com - November 1 at 6:23 PM
finance.yahoo.com logoMediWound to Present at 11th Annual Wells Fargo Healthcare Conference (NASDAQ:MDWD)
finance.yahoo.com - August 26 at 9:06 AM
finance.yahoo.com logoMediWound’s NexoBrid and EscharEx to be Featured at International Society for Burn Injuries 2016 (NASDAQ:MDWD)
finance.yahoo.com - August 24 at 9:14 AM
seekingalpha.com logoHealthcare ratings roundup - new coverage (NASDAQ:MDWD)
seekingalpha.com - August 19 at 9:10 AM
finance.yahoo.com logoMediWound (MDWD) in Focus: Stock Moves 23.4% Higher (NASDAQ:MDWD)
finance.yahoo.com - August 18 at 9:12 AM
finance.yahoo.com logoCoverage initiated on MediWound by Wells Fargo (NASDAQ:MDWD)
finance.yahoo.com - August 17 at 6:20 PM
sg.finance.yahoo.com logoMediWound reports 2Q loss (NASDAQ:MDWD)
sg.finance.yahoo.com - July 28 at 10:01 AM
einnews.com logoMediWound Reports Second Quarter 2016 Financial Results (NASDAQ:MDWD)
www.einnews.com - July 28 at 9:18 AM
biz.yahoo.com logoQ2 2016 Mediwound Ltd Earnings Release - 07:00 am ET (NASDAQ:MDWD)
biz.yahoo.com - July 28 at 7:07 AM
finance.yahoo.com logoMediWound to Host Second Quarter 2016 Financial Results Conference Call on July 28, 2016 at 8:30 a.m. Eastern Time (NASDAQ:MDWD)
finance.yahoo.com - July 21 at 8:00 AM
finance.yahoo.com logoBear of the Day: Valeant Pharma (VRX) (NASDAQ:MDWD)
finance.yahoo.com - July 14 at 7:01 AM
capitalcube.com logoMediWound Ltd. :MDWD-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 (NASDAQ:MDWD)
www.capitalcube.com - June 28 at 1:16 PM
finance.yahoo.com logoMediWound’s NexoBrid® Receives Reimbursement in Italy (NASDAQ:MDWD)
finance.yahoo.com - June 7 at 7:00 AM
finance.yahoo.com logoData Published in Bone & Joint Research Supports MediWound’s Bromelain-Based Enzyme for the Release of Dupuytren’s Contracture (NASDAQ:MDWD)
finance.yahoo.com - May 31 at 7:30 AM
realistinvestor.com logoMediWound Ltd. (NASDAQ:MDWD) Daily Sentiment Score Of 0.31 - RealistInvestor.com (NASDAQ:MDWD)
www.realistinvestor.com - May 30 at 6:09 PM
finance.yahoo.com logoMediWound’s NexoBrid® Highlighted in “Best Oral Presentation” at the British Burn Association 49th Annual Conference and Scientific Meeting (NASDAQ:MDWD)
finance.yahoo.com - May 19 at 7:00 AM
thestreet.com logoMediWound's NexoBrid® To Be Highlighted In Presentations At The American Burn Association 48th Annual Meeting (NASDAQ:MDWD)
www.thestreet.com - May 2 at 6:46 PM
finance.yahoo.com logoMediWound’s NexoBrid® to be Highlighted in Presentations at the American Burn Association 48th Annual Meeting (NASDAQ:MDWD)
finance.yahoo.com - May 2 at 7:00 AM
News IconMediwound Limited Ord (NASDAQ:MDWD) Short Interest Decreased By 0.28% - B.O.D.Y Confidential (NASDAQ:MDWD)
www.bodyconfidential.com - May 2 at 5:15 AM
finance.yahoo.com logoMediWound’s NexoBrid to be Available in Japan through Kaken Pharmaceuticals Co., Ltd. (NASDAQ:MDWD)
finance.yahoo.com - April 26 at 7:00 AM
News IconQ1 Results: Mediwound Ltd (MDWD) - share market updates (press release) (NASDAQ:MDWD)
sharemarketupdates.com - April 23 at 6:22 PM
capitalcube.com logoMediWound Ltd. :MDWD-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:MDWD)
www.capitalcube.com - April 22 at 9:55 AM
News IconConference Call Info: Mediwound Ltd (NASDAQ:MDWD) - share market updates (press release) (NASDAQ:MDWD)
sharemarketupdates.com - April 21 at 6:44 PM
finance.yahoo.com logoEdited Transcript of MDWD earnings conference call or presentation 21-Apr-16 12:30pm GMT (NASDAQ:MDWD)
finance.yahoo.com - April 21 at 3:12 PM
finance.yahoo.com logoMediWound to Present at the 36th Annual Cowen Health Care Conference (NASDAQ:MDWD)
finance.yahoo.com - March 7 at 7:00 AM

Social

What is MediWound's stock symbol?

MediWound trades on the NASDAQ under the ticker symbol "MDWD."

Where is MediWound's stock going? Where will MediWound's stock price be in 2017?

6 brokers have issued 1-year target prices for MediWound's shares. Their forecasts range from $10.00 to $14.00. On average, they anticipate MediWound's stock price to reach $12.20 in the next twelve months.

When will MediWound announce their earnings?

MediWound is scheduled to release their next quarterly earnings announcement on Wednesday, April, 19th 2017.

Who owns MediWound stock?

MediWound's stock is owned by a number of of retail and institutional investors. Top institutional investors include Broadfin Capital LLC (2.89%), Menora Mivtachim Holdings LTD. (0.74%) and Renaissance Technologies LLC (0.34%).

Who bought MediWound stock? Who is buying MediWound stock?

MediWound's stock was bought by a variety of institutional investors in the last quarter, including Broadfin Capital LLC and Renaissance Technologies LLC.

How do I buy MediWound stock?

Shares of MediWound can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of MediWound stock cost?

One share of MediWound stock can currently be purchased for approximately $5.85.

MediWound (NASDAQ:MDWD) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for MediWound (NASDAQ:MDWD)

Earnings History Chart

Earnings by Quarter for MediWound (NASDAQ:MDWD)

Dividend History Chart

Dividend Payments by Quarter for MediWound (NASDAQ:MDWD)

Last Updated on 2/25/2017 by MarketBeat.com Staff